Vilazodone (Viibryd) Manufacturing Plant Project Report 2025: Project Report and Setup Guide
Introduction
Vilazodone, marketed under the brand name Viibryd, is an antidepressant medication used primarily in the treatment of major depressive disorder (MDD) in adults. It is classified as a selective serotonin reuptake inhibitor (SSRI) and a partial agonist of serotonin 5-HT1A receptors. Its dual mechanism of action helps in enhancing serotonin levels in the brain, offering a unique...
0 Comments
0 Shares
497 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt